Clinical Trial Update: Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs

View source ↗

Summary

A completed Takeda trial evaluated long-term Takepron for preventing recurrence of NSAID-associated gastric or duodenal ulcers; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer

Drugs mentioned

• Takepron

Snippet

Sponsor: Takeda | Conditions: Gastric or Duodenal Ulcers | Status: COMPLETED | Results posted: 2015-10-09